102 related articles for article (PubMed ID: 8949947)
1. Coagulation protein function. IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway.
Brecher AS; Koterba AP; Basista MH
Alcohol; 1996; 13(6):539-45. PubMed ID: 8949947
[TBL] [Abstract][Full Text] [Related]
2. Coagulation protein function. III. Effect of acetaldehyde upon the activation of prothrombin.
Brecher A; Koterba AP; Basista MH
Alcohol; 1996; 13(5):423-9. PubMed ID: 8888937
[TBL] [Abstract][Full Text] [Related]
3. Differences between human and rabbit coagulation factor X-implications for in vivo models of thrombosis.
Edwards ST; Betz A; James HL; Thompson E; Yonkovich SJ; Sinha U
Thromb Res; 2002 Apr; 106(1):71-9. PubMed ID: 12165292
[TBL] [Abstract][Full Text] [Related]
4. The mode of action of sugammadex on coagulation.
Kruithof AC; Kluft C; de Kam PJ; Laterveer RH; Moerland M; Burggraaf J
Int J Clin Pharmacol Ther; 2021 Feb; 59(2):89-98. PubMed ID: 33155541
[TBL] [Abstract][Full Text] [Related]
5. The influence of acetaldehyde and glycosaminoglycans upon factor Xa- and factor X-deficient plasma.
Brecher AS; Hommema EL
Can J Physiol Pharmacol; 2002 Sep; 80(9):879-86. PubMed ID: 12430983
[TBL] [Abstract][Full Text] [Related]
6. Measurement of human activated factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assay.
Jesty J; Morrison SA; Harpel PC
Anal Biochem; 1984 May; 139(1):158-67. PubMed ID: 6742427
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of factor X activity by factor X-specific monoclonal antibodies.
Ouellette LA; Messier TL; Church WR
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):563-74. PubMed ID: 1450323
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the generation and inhibition of activated coagulation factor X in pure systems and in human plasma.
Jesty J
J Biol Chem; 1986 Jul; 261(19):8695-702. PubMed ID: 3722168
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom.
Stefansson S; Kini RM; Evans HJ
Thromb Res; 1989 Aug; 55(4):481-91. PubMed ID: 2814939
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
11. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
Brecher AS; Hellman K; Basista MH
Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
[TBL] [Abstract][Full Text] [Related]
12. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
13. Coagulation protein function. II. Influence of thiols upon acetaldehyde effects.
Koterba AP; Smolen S; Joseph A; Basista MH; Brecher AS
Alcohol; 1995; 12(1):49-57. PubMed ID: 7748514
[TBL] [Abstract][Full Text] [Related]
14. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
[TBL] [Abstract][Full Text] [Related]
15. The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor X.
Rapaport SI; Toneff T; Rimon A; Warn-Cramer BJ
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):409-16. PubMed ID: 9081698
[TBL] [Abstract][Full Text] [Related]
16. Activation of decarboxyfactor X by a protein from Russell's viper venom. Purification and partial characterization of activated decarboxyfactor X.
Lindhout MJ; Kop-Klaassen BH; Hemker HC
Biochim Biophys Acta; 1978 Apr; 533(2):327-41. PubMed ID: 417734
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of apixaban using a viscoelastic coagulation assay with Russell's viper venom reagent.
Suzuki K; Katori N; Kimura Y; Terui T; Sunaga H; Kobayashi S; Uezono S
JA Clin Rep; 2021 May; 7(1):42. PubMed ID: 33956242
[TBL] [Abstract][Full Text] [Related]
18. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
Estry DW; Tishkoff GH
Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
[TBL] [Abstract][Full Text] [Related]
19. The effect of glycosaminoglycans with acetaldehyde on the activation of prothrombin.
Brecher AS; Adamu MT
Can J Physiol Pharmacol; 2005 May; 83(5):431-8. PubMed ID: 15897925
[TBL] [Abstract][Full Text] [Related]
20. An acidic phospholipase A(2) (RVVA-PLA(2)-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor Xa in a phospholipids/Ca(2+) independent manner.
Saikia D; Thakur R; Mukherjee AK
Toxicon; 2011 May; 57(6):841-50. PubMed ID: 21356226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
